1,2,3-Triazole-linked 5-benzylidene (thio)barbiturates as novel tyrosinase inhibitors and free-radical scavengers. 2020

Sara Ranjbar, and Parisa-Sadat Shahvaran, and Najmeh Edraki, and Mahsima Khoshneviszadeh, and Mahdieh Darroudi, and Yaghoub Sarrafi, and Mahshid Hamzehloueian, and Mehdi Khoshneviszadeh
Pharmaceutical Sciences Research Center, Shiraz University of Medical Sciences, Shiraz, Iran.

In this study, benzyl-1,2,3-triazole-linked 5-benzylidene (thio)barbiturate derivatives 7a-d and 8a-h were designed as potential tyrosinase inhibitors and free-radical scavengers. The twelve derivatives were synthesized via the [3+2] cycloaddition reaction of the corresponding benzyl azide as a dipole and the corresponding alkyne as a dipolarophile in the presence of copper(I) species, generated in situ from copper(II)/ascorbate. The thiobarbiturate derivative 8h and the barbiturate derivative 8b bearing 4-fluoro and 4-bromo groups on the benzyl-triazole moiety were found to be the most potent tyrosinase inhibitors with IC50 values of 24.6 ± 0.9 and 26.8 ± 0.8 μM, respectively. Almost all the compounds showed a good radical scavenging activity with EC50 values in the range of 29.9-324.9 μM. Derivatives 7a, 8f, and 8h were the most potent free-radical scavengers with EC50 values of 29.9 ± 0.8, 36.8 ± 0.9, and 39.2 ± 1.1 μM, respectively. The kinetic analysis revealed that compound 8h was a mixed-type tyrosinase inhibitor. The molecular docking analysis indicated that 8b and 8h were well accommodated in the active site of the tyrosinase enzyme and possessed the most negative binding energy values of -8.55 and -8.81 kcal/mol, respectively. Moreover, it was found that the two residues, Asn81 and Glu322, played a significant role in forming stable enzyme-inhibitor complexes.

UI MeSH Term Description Entries
D004791 Enzyme Inhibitors Compounds or agents that combine with an enzyme in such a manner as to prevent the normal substrate-enzyme combination and the catalytic reaction. Enzyme Inhibitor,Inhibitor, Enzyme,Inhibitors, Enzyme
D001463 Barbiturates A class of chemicals derived from barbituric acid or thiobarbituric acid. Many of these are GABA MODULATORS used as HYPNOTICS AND SEDATIVES, as ANESTHETICS, or as ANTICONVULSANTS.
D013329 Structure-Activity Relationship The relationship between the chemical structure of a compound and its biological or pharmacological activity. Compounds are often classed together because they have structural characteristics in common including shape, size, stereochemical arrangement, and distribution of functional groups. Relationship, Structure-Activity,Relationships, Structure-Activity,Structure Activity Relationship,Structure-Activity Relationships
D014230 Triazoles Heterocyclic compounds containing a five-membered ring with two carbon atoms and three nitrogen atoms with the molecular formula C2H3N3. Triazole
D014442 Monophenol Monooxygenase An enzyme of the oxidoreductase class that catalyzes the reaction between L-tyrosine, L-dopa, and oxygen to yield L-dopa, dopaquinone, and water. It is a copper protein that acts also on catechols, catalyzing some of the same reactions as CATECHOL OXIDASE. EC 1.14.18.1. Dopa Oxidase,Phenoloxidase,Tyrosinase,Cresolase,Phenol Oxidase,Phenoloxidase A,Phenoloxidase B,Monooxygenase, Monophenol,Oxidase, Dopa,Oxidase, Phenol
D016166 Free Radical Scavengers Substances that eliminate free radicals. Among other effects, they protect PANCREATIC ISLETS against damage by CYTOKINES and prevent myocardial and pulmonary REPERFUSION INJURY. Free Radical Scavenger,Radical Scavenger, Free,Scavenger, Free Radical,Scavengers, Free Radical
D062105 Molecular Docking Simulation A computer simulation technique that is used to model the interaction between two molecules. Typically the docking simulation measures the interactions of a small molecule or ligand with a part of a larger molecule such as a protein. Molecular Docking,Molecular Docking Simulations,Molecular Docking Analysis,Analysis, Molecular Docking,Docking Analysis, Molecular,Docking Simulation, Molecular,Docking, Molecular,Molecular Docking Analyses,Molecular Dockings,Simulation, Molecular Docking
D020128 Inhibitory Concentration 50 The concentration of a compound needed to reduce population growth of organisms, including eukaryotic cells, by 50% in vitro. Though often expressed to denote in vitro antibacterial activity, it is also used as a benchmark for cytotoxicity to eukaryotic cells in culture. IC50,Concentration 50, Inhibitory

Related Publications

Sara Ranjbar, and Parisa-Sadat Shahvaran, and Najmeh Edraki, and Mahsima Khoshneviszadeh, and Mahdieh Darroudi, and Yaghoub Sarrafi, and Mahshid Hamzehloueian, and Mehdi Khoshneviszadeh
July 2014, Bioorganic & medicinal chemistry,
Sara Ranjbar, and Parisa-Sadat Shahvaran, and Najmeh Edraki, and Mahsima Khoshneviszadeh, and Mahdieh Darroudi, and Yaghoub Sarrafi, and Mahshid Hamzehloueian, and Mehdi Khoshneviszadeh
February 2011, European journal of medicinal chemistry,
Sara Ranjbar, and Parisa-Sadat Shahvaran, and Najmeh Edraki, and Mahsima Khoshneviszadeh, and Mahdieh Darroudi, and Yaghoub Sarrafi, and Mahshid Hamzehloueian, and Mehdi Khoshneviszadeh
June 2019, Bioorganic & medicinal chemistry,
Sara Ranjbar, and Parisa-Sadat Shahvaran, and Najmeh Edraki, and Mahsima Khoshneviszadeh, and Mahdieh Darroudi, and Yaghoub Sarrafi, and Mahshid Hamzehloueian, and Mehdi Khoshneviszadeh
August 2009, Bioorganic & medicinal chemistry letters,
Sara Ranjbar, and Parisa-Sadat Shahvaran, and Najmeh Edraki, and Mahsima Khoshneviszadeh, and Mahdieh Darroudi, and Yaghoub Sarrafi, and Mahshid Hamzehloueian, and Mehdi Khoshneviszadeh
July 2018, Chemistry & biodiversity,
Sara Ranjbar, and Parisa-Sadat Shahvaran, and Najmeh Edraki, and Mahsima Khoshneviszadeh, and Mahdieh Darroudi, and Yaghoub Sarrafi, and Mahshid Hamzehloueian, and Mehdi Khoshneviszadeh
May 2012, International journal of biological macromolecules,
Sara Ranjbar, and Parisa-Sadat Shahvaran, and Najmeh Edraki, and Mahsima Khoshneviszadeh, and Mahdieh Darroudi, and Yaghoub Sarrafi, and Mahshid Hamzehloueian, and Mehdi Khoshneviszadeh
September 2019, Bioorganic chemistry,
Sara Ranjbar, and Parisa-Sadat Shahvaran, and Najmeh Edraki, and Mahsima Khoshneviszadeh, and Mahdieh Darroudi, and Yaghoub Sarrafi, and Mahshid Hamzehloueian, and Mehdi Khoshneviszadeh
February 2019, Chemical biology & drug design,
Sara Ranjbar, and Parisa-Sadat Shahvaran, and Najmeh Edraki, and Mahsima Khoshneviszadeh, and Mahdieh Darroudi, and Yaghoub Sarrafi, and Mahshid Hamzehloueian, and Mehdi Khoshneviszadeh
January 2016, Chemical & pharmaceutical bulletin,
Sara Ranjbar, and Parisa-Sadat Shahvaran, and Najmeh Edraki, and Mahsima Khoshneviszadeh, and Mahdieh Darroudi, and Yaghoub Sarrafi, and Mahshid Hamzehloueian, and Mehdi Khoshneviszadeh
March 2012, European journal of medicinal chemistry,
Copied contents to your clipboard!